Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study

• Main Authors: Kensuke Abe (Author), Junji Imamura (Author), Akiko Sasaki (Author), Tomoko Suzuki (Author), Satomi Kamio (Author), Taku Obara (Author), Toshihiro Ito (Author)
• Formato: Livro
• Publicado em: BMC, 2024-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Continued use of tenofovir disoproxil fumarate (TDF), an antiretroviral drug, causes renal function decline and tubular damage in individuals with HIV. While tenofovir alafenamide fumarate (TAF) may have less damaging effects, it causes weight gain and abnormal lipid metabolism....